Tissue toxicokinetics of perfluoro compounds with single and chronic low doses in male rats.

Katsumi Iwabuchi,Norimasa Senzaki,Daichi Mazawa,Itaru Sato,Michihiro Hara,Fukiko Ueda,Wei Liu,Shuji Tsuda
DOI: https://doi.org/10.2131/jts.42.301
2017-01-01
Abstract:To examine the kinetics of low doses of perfluoro compounds (PFCs), we administered perfluorohexanoic acid (C6A), perfluorooctanoic acid (C8A), perfluorononanoic acid (C9A) and perfluorooctane sulfonate (C8S) with a single oral dose (50-100 mu g/kg BW), and in drinking water at 1, 5, and 25 mu g/L for one and three months to male rats; and examined the distribution in the brain, heart, liver, spleen, kidney, whole blood and serum. C6A was very rapidly absorbed, distributed and eliminated from the tissues with nearly the same tissue t(1/2), of 2-3 hr. Considering serum Vd, and the tissue delivery, C6A was mainly in the serum with the lowest delivery to the brain; and no tissue accumulation was observed in the chronic studies as estimated from the single dose study. For the other PFCs, the body seemed to be an assortment of independent one-compartments with a longer elimination t(1/2), for the liver than the serum. The concentration ratio of liver/serum increased gradually from C-0 to a steady state. The high binding capacity of plasma protein may be the reason for the unusual kinetics, with only a very small fraction of free PFCs moving gradually to the liver. Although the tissue specific distribution was time dependent and different among the PFCs, the Vd and k(e) of each tissue were constant throughout the study. The possibility of extremely high C6A accumulation in the human brain and liver was suggested, by comparing the steady state tissue concentration of this study with the human data reported by Perez et al. (2013).
What problem does this paper attempt to address?